Trial Profile
Identification of the Prognostic Factors of Stage II Colon Cancer Patients Receiving Adjuvant Chemotherapy With UFT
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Tegafur/uracil (Primary)
- Indications Colorectal cancer
- Focus Pharmacodynamics
- 03 Oct 2016 New trial record